FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Murielle Rinaldi-Carmona

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Physiology

Binding, Competitive

Co-author Network

Publications

TOP 3
Laurent Hortala; Murielle Rinaldi-Carmona; Christian Congy; Laurent Boulu; Freddy Sadoun; Gérard Fabre; Olivier Finance; Francis Barth
Rational design of a novel peripherally-restricted, orally active CB(1) cannabinoid antagonist containing a 2,3-diarylpyrrole motif.
Yong-Yao Cui; Bruno D'Agostino; Paul-Andre Risse; Guiseppina Marrocco; Emmanuel Naline; Yong Zhang; Hong-Zhuan Chen; Olivier Finance; Murielle Rinaldi-Carmona; Francesco Rossi; Charles Advenier
Cannabinoid CB(2) receptor activation prevents bronchoconstriction and airway oedema in a model of gastro-oesophageal reflux.
Gérard Le-Fur; Murielle Rinaldi-Carmona; Francis Barth; John Alexander
[Pharmacology of cannabinoid receptors].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Murielle Rinaldi-Carmona (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Laurent Hortala; Murielle Rinaldi-Carmona; Christian Congy; Laurent Boulu; Freddy Sadoun; Gérard Fabre; Olivier Finance; Francis Barth
Rational design of a novel peripherally-restricted, orally active CB(1) cannabinoid antagonist containing a 2,3-diarylpyrrole motif.
Bioorganic & medicinal chemistry letters 2010;20(15):4573-7.
2007: Yong-Yao Cui; Bruno D'Agostino; Paul-Andre Risse; Guiseppina Marrocco; Emmanuel Naline; Yong Zhang; Hong-Zhuan Chen; Olivier Finance; Murielle Rinaldi-Carmona; Francesco Rossi; Charles Advenier
Cannabinoid CB(2) receptor activation prevents bronchoconstriction and airway oedema in a model of gastro-oesophageal reflux.
European journal of pharmacology 2007;573(1-3):206-13.
2007: Gérard Le-Fur; Murielle Rinaldi-Carmona; Francis Barth; John Alexander
[Pharmacology of cannabinoid receptors].
Bulletin de l'Académie nationale de médecine 2007;191(4-5):933-8; discussion 938-40.
2005: M Yu Bobrov; Natalia Gretskaya; Olivier Payet; Vladimir V. Bezuglov; Thierry Durand; Laurence Maurin; Frank Tourrel; Oumeya Adjali; Murielle Rinaldi-Carmona; Agnès Muller
Different pharmacological profile of two closely related endocannabinoid ester analogs.
Life sciences 2005;77(13):1425-40.
2004: Murielle Rinaldi-Carmona; Francis Barth; Christian Congy; Serge Martinez; Didier Oustric; Alain Pério; Martine Poncelet; Jeanne Maruani; Michèle Arnone; Olivier Finance; Philippe Soubrié; Gérard Le-Fur
SR147778 [5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a new potent and selective antagonist of the CB1 cannabinoid receptor: biochemical and pharmacological characterization.
The Journal of pharmacology and experimental therapeutics 2004;310(3):905-14.
2002: Marco Landi; Tiziano Croci; Murielle Rinaldi-Carmona; Jean-Pierre Maffrand; Gérard Le-Fur; Luciano Manara
Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB(1) receptors.
European journal of pharmacology 2002;450(1):77-83.
2002: William B Mathews; Ursula Scheffel; Paige A Rauseo; Hayden T Ravert; Richard A Frank; George J Ellames; John M Herbert; Francis Barth; Murielle Rinaldi-Carmona; Robert F Dannals
Carbon-11 labeled radioligands for imaging brain cannabinoid receptors.
Nuclear medicine and biology 2002;29(6):671-7.
2002: Luciano Manara; Tiziano Croci; Fabio Guagnini; Murielle Rinaldi-Carmona; Jean-Pierre Maffrand; Gérard Le-Fur; Sylvain Mukenge; Gianfranco Ferla
Functional assessment of neuronal cannabinoid receptors in the muscular layers of human ileum and colon.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2002;34(4):262-9.
2000: William B Mathews; Ursula Scheffel; PA Finley; Hayden T Ravert; R A Frank; Murielle Rinaldi-Carmona; Francis Barth; Robert F Dannals
Biodistribution of [18F] SR144385 and [18F] SR147963: selective radioligands for positron emission tomographic studies of brain cannabinoid receptors.
Nuclear medicine and biology 2000;27(8):757-62.
2000: Paul R Gouldson; B Calandra; P Legoux; A Kernéis; Murielle Rinaldi-Carmona; Francis Barth; Gérard Le-Fur; Pascual Ferrara; David Shire
Mutational analysis and molecular modelling of the antagonist SR 144528 binding site on the human cannabinoid CB(2) receptor.
European journal of pharmacology 2000;401(1):17-25.
1999: Francis Barth; Murielle Rinaldi-Carmona
The development of cannabinoid antagonists.
Current medicinal chemistry 1999;6(8):745-55.
1999: M Portier; Murielle Rinaldi-Carmona; F Pecceu; Thérèse Combes; C Poinot-Chazel; B Calandra; Francis Barth; Gérard Le-Fur; Pierre Casellas
SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist.
The Journal of pharmacology and experimental therapeutics 1999;288(2):582-9.
1999: David Shire; B Calandra; Monsif Bouaboula; Francis Barth; Murielle Rinaldi-Carmona; Pierre Casellas; Pascual Ferrara
Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528.
Life sciences 1999;65(6-7):627-35.
1998: Tiziano Croci; Luciano Manara; G Aureggi; Fabio Guagnini; Murielle Rinaldi-Carmona; Jean-Pierre Maffrand; Gérard Le-Fur; Sylvain Mukenge; Gianfranco Ferla
In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum.
British journal of pharmacology 1998;125(7):1393-5.
1998: Murielle Rinaldi-Carmona; A Le Duigou; Didier Oustric; Francis Barth; Monsif Bouaboula; Pierre Carayon; Pierre Casellas; Gérard Le-Fur
Modulation of CB1 cannabinoid receptor functions after a long-term exposure to agonist or inverse agonist in the Chinese hamster ovary cell expression system.
The Journal of pharmacology and experimental therapeutics 1998;287(3):1038-47.
1998: Jean-Marie Derocq; Monsif Bouaboula; Jean Marchand; Murielle Rinaldi-Carmona; M Ségui; Pierre Casellas
The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines.
FEBS letters 1998;425(3):419-25.
1998: Murielle Rinaldi-Carmona; Francis Barth; J Millan; Jean-Marie Derocq; Pierre Casellas; C Congy; Didier Oustric; M Sarran; Monsif Bouaboula; B Calandra; M Portier; David Shire; J C Brelière; Gérard Le-Fur
SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor.
The Journal of pharmacology and experimental therapeutics 1998;284(2):644-50.
1997: Monsif Bouaboula; S Perrachon; L Milligan; X Canat; Murielle Rinaldi-Carmona; M Portier; Francis Barth; B Calandra; F Pecceu; J Lupker; Jean-Pierre Maffrand; Gérard Le-Fur; Pierre Casellas
A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions.
The Journal of biological chemistry 1997;272(35):22330-9.
1997: M Jung; Roselyne Calassi; Murielle Rinaldi-Carmona; P Chardenot; Gérard Le-Fur; Philippe Soubrié; Florence Oury-Donat
Characterization of CB1 receptors on rat neuronal cell cultures: binding and functional studies using the selective receptor antagonist SR 141716A.
Journal of neurochemistry 1997;68(1):402-9.
1996: Murielle Rinaldi-Carmona; B Calandra; David Shire; Monsif Bouaboula; D Oustric; Francis Barth; Pierre Casellas; Pascual Ferrara; Gérard Le-Fur
Characterization of two cloned human CB1 cannabinoid receptor isoforms.
The Journal of pharmacology and experimental therapeutics 1996;278(2):871-8.
1996: J P Terranova; J J Storme; N Lafon; A Péŕio; Murielle Rinaldi-Carmona; Gérard Le-Fur; Philippe Soubrié
Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716.
Psychopharmacology 1996;126(2):165-72.
1996: David Shire; B Calandra; Murielle Rinaldi-Carmona; D Oustric; B Pessègue; O Bonnin-Cabanne; Gérard Le-Fur; Daniel Caput; Pascual Ferrara
Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor.
Biochimica et biophysica acta 1996;1307(2):132-6.
1996: Monsif Bouaboula; C Poinot-Chazel; Jean Marchand; X Canat; Bernard Bourrié; Murielle Rinaldi-Carmona; B Calandra; Gérard Le-Fur; Pierre Casellas
Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression.
European journal of biochemistry / FEBS 1996;237(3):704-11.
1996: Murielle Rinaldi-Carmona; F Pialot; C Congy; E Redon; Francis Barth; A Bachy; JC Brelière; Philippe Soubrié; Gérard Le-Fur
Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain.
Life sciences 1996;58(15):1239-47.
1995: Monsif Bouaboula; C Poinot-Chazel; Bernard Bourrié; X Canat; B Calandra; Murielle Rinaldi-Carmona; Gérard Le-Fur; Pierre Casellas
Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1.
The Biochemical journal 1995;312 ( Pt 2)():637-41.
1995: Christiane Gueudet; Vincent Santucci; Murielle Rinaldi-Carmona; Philippe Soubrié; Gérard Le-Fur
The CB1 cannabinoid receptor antagonist SR 141716A affects A9 dopamine neuronal activity in the rat.
Neuroreport 1995;6(10):1421-5.
1995: Monsif Bouaboula; Bernard Bourrié; Murielle Rinaldi-Carmona; David Shire; Gérard Le-Fur; Pierre Casellas
Stimulation of cannabinoid receptor CB1 induces krox-24 expression in human astrocytoma cells.
The Journal of biological chemistry 1995;270(23):13973-80.
1995: David Shire; C Carillon; Mourad Kaghad; B Calandra; Murielle Rinaldi-Carmona; Gérard Le-Fur; Daniel Caput; Pascual Ferrara
An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing.
The Journal of biological chemistry 1995;270(8):3726-31.
1995: Murielle Rinaldi-Carmona; Francis Barth; M Héaulme; R Alonso; David Shire; C Congy; Philippe Soubrié; JC Brelière; Gérard Le-Fur
Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist.
Life sciences 1995;56(23-24):1941-7.
1994: Murielle Rinaldi-Carmona; Francis Barth; M Héaulme; David Shire; B Calandra; C Congy; S Martinez; J Maruani; G Néliat; Daniel Caput
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor.
FEBS letters 1994;350(2-3):240-4.
1994: Murielle Rinaldi-Carmona; V Prabonnaud; Monsif Bouaboula; C Poinot-Chazel; Pierre Casellas; Gérard Le-Fur; J M Herbert
Regulation of 5-hydroxytryptamine2 (5-HT2) receptor expression in cultured rat aortic smooth muscle cells by SR 46349B, a selective 5-HT2 receptor antagonist.
The Journal of biological chemistry 1994;269(1):396-401.
1994: Murielle Rinaldi-Carmona; C Congy; P Pointeau; H Vidal; JC Brelière; Gérard Le-Fur
Identification of binding sites for SR 46349B, a 5-hydroxytryptamine2 receptor antagonist, in rodent brain.
Life sciences 1994;54(2):119-27.
1993: Murielle Rinaldi-Carmona; Monsif Bouaboula; C Congy; Florence Oury-Donat; Jacques Simiand; David Shire; Pierre Casellas; Philippe Soubrié; JC Brelière; Gérard Le-Fur
Up-regulation of 5-HT2 receptors in the rat brain by repeated administration of SR 46349B, a selective 5-HT2 receptor antagonist.
European journal of pharmacology 1993;246(1):73-80.
1993: Murielle Rinaldi-Carmona; C Congy; Jacques Simiand; Florence Oury-Donat; Philippe Soubrie; J C Breliere; Gérard Le-Fur
Repeated administration of SR 46349B, a selective 5-hydroxytryptamine2 antagonist, up-regulates 5-hydroxytryptamine2 receptors in mouse brain.
Molecular pharmacology 1993;43(1):84-9.
1992: Murielle Rinaldi-Carmona; C Congy; Vincent Santucci; Jacques Simiand; B Gautret; G Neliat; B Labeeuw; Gérard Le-Fur; Philippe Soubrie; J C Breliere
Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist.
The Journal of pharmacology and experimental therapeutics 1992;262(2):759-68.